11/23/2021 | Press release | Archived content
November 23, 2021
Weil advised Advent International in its acquisition of a substantial minority stake in Iodine Software, LLC, a leading healthcare AI company, in a transaction that valued Iodine at more than $1 billion. Bain Capital Ventures and Silversmith Capital Partners, which invested in the Company in 2018, will remain shareholders. The transaction closed on November 23, 2021. Financial terms of the transaction were not disclosed.
The Weil team that advised Advent International was led by Private Equity partner Marilyn French Shaw and included Private Equity partner Ramona Nee and Private Equity associates Michael Bill, Ryan McCarthy, David Tews and Zhengyan Gu (Not Yet Admitted in the Commonwealth of Massachusetts). The team also included Tax partner Hillel Jacobson; Tax associate Natalia Pierotti; Executive Compensation & Benefits partner Amy Rubin; Executive Compensation & Benefits associate Robin Caskey; Technology & IP Transactions partner Jeffrey Osterman; Technology & IP Transactions/Privacy counsel Alexa Chu Clinton; Technology & IP Transactions/Privacy associates David Merck, Maryann Thompson and Mirish Shah; Environmental Head Annemargaret Connolly; Regulatory Transactions counsel John O'Loughlin; Employment Litigation partner Nicholas Pappas; Employment Litigation associate Omar Abdel-Hamid (Not Yet Admitted in New York); and Litigation associate Shannon Coffey (Not Yet Admitted in New York).